Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Buy
+31,547
New +$186K ﹤0.01% 3283
2025
Q2
Sell
-31,562
Closed -$380K 3383
2025
Q1
$380K Buy
+31,562
New +$413K ﹤0.01% 2456
2023
Q4
Sell
-56,802
Closed -$519K 2493
2023
Q3
$519K Sell
56,802
-82,341
-59% -$738K 0.01% 1660
2023
Q2
$1.01M Buy
139,143
+33,853
+32% +$292K 0.01% 1310
2023
Q1
$891K Buy
105,290
+2,394
+2% +$21.6K 0.01% 1272
2022
Q4
$773K Buy
102,896
+20,902
+25% +$162K 0.02% 1292
2022
Q3
$660K Buy
81,994
+51,151
+166% +$542K 0.01% 1200
2022
Q2
$358K Buy
+30,843
New +$364K 0.01% 1457
2020
Q1
Sell
-34,797
Closed -$423K 1123
2019
Q4
$423K Buy
+34,797
New +$491K 0.02% 769

Other funds holding EOLS

Paul Tudor Jones's EOLS Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Evolus (EOLS) in Q2 2026: 31,547 shares worth $219K. The stake represents ﹤0.01% of the portfolio and ranks #3283 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in EOLS as recently as Q1 2025.

Paul Tudor Jones first reported a position in EOLS in Q4 2019 and has held it in 9 quarters since. The position peaked at $1.01M in Q2 2023. 157 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Paul Tudor Jones held 31,547 shares of Evolus worth $219K as of Q2 2026.
  • Evolus was a new Paul Tudor Jones position in Q2 2026.
  • Evolus made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #3283 holding.
  • Paul Tudor Jones first reported a position in Evolus in Q4 2019 and has held it in 9 quarters since.
  • Paul Tudor Jones's Evolus position peaked at $1.01M in Q2 2023.
  • 157 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.